Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ADALIMUMAB-AATY (Yuflyma) and ADALIMUMAB-AQVH (YUSIMRY) — clinical data, side effects, and patient experiences.
Yuflyma · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
YUSIMRY · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 8 Reddit discussions
ADALIMUMAB-AATY
0%
positive
2 threads
ADALIMUMAB-AQVH
17%
positive
6 threads
% of discussions mentioning each side effect
2 Reddit threads analysed for ADALIMUMAB-AATY
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
3 upvotes
Just received a letter that my company will no longer cover Humira and for my adult child UC and offered generic adalimumab aaty or adalimumab-adaz instead. When first diagnosed, my adult child went through 3 different drugs until we found the right match that finally gave her life back and another
Hello Everyone! My insurance recently switched me from Humira to Adalimumab-aaty, which is a biosimilar. When I was taking Humira I barely felt the injection, but the adalimumab injections REALLY hurt! Has anyone else had this experience?? Any tips?
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
6 Reddit threads analysed for ADALIMUMAB-AQVH
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
22 upvotes
Most discussed side effects in community
$995 for a carton of 2 auto injectors vs Humira's $6922, good news for the patients. We can hope for more price reductions as the market is expecting at least 11 Humira biosimilars to be released.
This is my first time posting in this community, although I’ve lurked ever since I was diagnosed a little over a month ago. About 3 years ago I woke up with insane elbow pain out of nowhere. That was the only joint that hurt, but it was super intense considering when I went to bed the night before
My employer switched insurance companies at the beginning of the year. I am now on WPS and use SmithRx and Costco Speciality Pharmacy to get my meds delivered to my house each month. I am on Zeposia and have been since January 2023 without any relapses and no side effects. I got a letter from Smith
I have Crohn's disease and I'm trying to narrow down what health plan I wish to go with. I used to be on Humira, but my old insurance in the private sector moved me to a biosimilar named Yusimry. Based on my research, none of the Federal plans cover or supply this drug, so I'm willing to move to a b
Hey chat, has anyone switched to Yusimry from Humira? Or experiences with other biosimilars? I’m considering making the jump due to insurance reasons so plz lmk your experiences with Yusimry or other products.
Hi, I'm totally new to this subreddit, so please bear with me! I was diagnosed with Juvenile Idiopathic Arthritis (However, it's Rheumatoid in my jaw) in October of 2021. I've been on Humira for 4 year now since then and it has worked pretty well (besides irritation at my injection site, handled wit
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Both ADALIMUMAB-AATY and ADALIMUMAB-AQVH belong to the TNF Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ADALIMUMAB-AATY is administered via Oral, whereas ADALIMUMAB-AQVH uses Subcutaneous. Route of administration can affect onset of action and patient adherence.
Both medications are approved for inducing major clinical response, inhibiting the progression of structural damage, inhibiting the progression of structural damage, posterior. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
ADALIMUMAB-AATY carries 4 FDA warnings. ADALIMUMAB-AQVH carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.